52 weeks ended | 53 weeks ended | ||||
1 June 2025 | 2 June 2024 | ||||
Notes | £m | £m | |||
Core revenue | |||||
Licensing revenue | |||||
Revenue | 4 | ||||
Cost of sales | ( | ( | |||
Core gross profit | |||||
Licensing gross profit | |||||
Gross profit | |||||
Operating expenses | 4,5 | ( | ( | ||
Core operating profit | |||||
Licensing operating profit | |||||
Operating profit | |||||
Finance income | 7 | ||||
Finance expenses | 8 | ( | ( | ||
Profit before taxation | 9 | ||||
Taxation | 10 | ( | ( | ||
Profit attributable to owners of the parent |
Notes | 52 weeks ended | 53 weeks ended | |
1 June 2025 | 2 June 2024 | ||
Basic earnings per ordinary share | 11 | ||
Diluted earnings per ordinary share | 11 |
52 weeks ended | 53 weeks ended | ||
1 June 2025 | 2 June 2024 | ||
Notes | £m | £m | |
Profit attributable to owners of the parent | |||
Other comprehensive income | |||
Exchange losses on translation of foreign operations | 29 | ( | ( |
Other comprehensive income for the period | ( | ( | |
Total comprehensive income attributable to owners of the parent |
Group | Company | ||||
1 June 2025 | 2 June 2024 | 1 June 2025 | 2 June 2024 | ||
Notes | £m | £m | £m | £m | |
Non-current assets | |||||
Goodwill | 13 | - | - | ||
Other intangible assets | 14 | - | - | ||
Property, plant and equipment | 15 | - | - | ||
Right-of-use assets | 16 | - | - | ||
Investments in subsidiaries | 17 | 30.6 | 30.6 | ||
Deferred tax assets | 18 | 0.2 | - | ||
Non-current receivables | 20 | 48.9 | 68.5 | ||
79.7 | 99.1 | ||||
Current assets | |||||
Inventories | 19 | - | - | ||
Trade and other receivables | 21 | 3.3 | 2.8 | ||
Current tax assets | - | - | |||
Cash and cash equivalents | 22 | 38.0 | 41.6 | ||
41.3 | 44.4 | ||||
Total assets | 121.0 | 143.5 | |||
Current liabilities | |||||
Lease liabilities | 24 | ( | ( | - | - |
Trade and other payables | 25 | ( | ( | (3.1) | (3.0) |
Current tax liabilities | ( | ( | - | - | |
Provisions for other liabilities and charges | 27 | ( | ( | - | - |
( | ( | (3.1) | (3.0) | ||
Net current assets | 38.2 | 41.4 | |||
Non-current liabilities | |||||
Lease liabilities | 24 | ( | ( | - | - |
Other non-current liabilities | 26 | ( | ( | (0.4) | (20.0) |
Deferred tax liabilities | 18 | ( | ( | - | - |
Provisions for other liabilities and charges | 27 | ( | ( | - | - |
( | ( | (0.4) | (20.0) | ||
Net assets | 117.5 | 120.5 | |||
Capital and reserves | |||||
Called up share capital | 28 | 1.6 | 1.6 | ||
Share premium account | 28 | 23.4 | 21.6 | ||
Other reserves | 29 | 0.1 | 0.1 | ||
Retained earnings | 92.4 | 97.2 | |||
Total equity | 117.5 | 120.5 |
Share | |||||
Called up | premium | Other reserves | Retained | Total | |
share capital | account | (note 29) | earnings | equity | |
£m | £m | £m | £m | £m | |
At 28 May 2023 and 29 May 2023 | |||||
Profit for the 53 weeks to 2 June 2024 | |||||
Exchange differences on translation of foreign operations | ( | ( | |||
Total comprehensive income for the period | ( | ||||
Transactions with owners: | |||||
Share-based payments | |||||
Shares issued under employee sharesave scheme (note 28) | |||||
Deferred tax credit relating to share options | |||||
Current tax credit relating to exercised share options | |||||
Dividends paid to Company shareholders | ( | ( | |||
Total transactions with owners | ( | ( | |||
At 2 June 2024 and 3 June 2024 | |||||
Profit for the 52 weeks to 1 June 2025 | |||||
Exchange differences on translation of foreign operations | ( | ( | |||
Total comprehensive income for the period | ( | ||||
Transactions with owners: | |||||
Share-based payments | |||||
Shares issued under employee sharesave scheme (note 28) | |||||
Deferred tax credit relating to share options | |||||
Current tax credit relating to exercised share options | |||||
Dividends paid to Company shareholders | ( | ( | |||
Total transactions with owners | ( | ( | |||
At 1 June 2025 |
Group | ||||
52 weeks ended 53 weeks ended | 52 weeks ended | |||
1 June 2025 | 2 June 2024 | 1 June 2025 | ||
Notes | £m | £m | ||
Cash flows from operating activities | ||||
Cash generated from operations | 30 | |||
UK corporation tax paid | ( | ( | ||
Overseas tax paid | ( | ( | ||
Net cash generated from operating activities | ||||
Cash flows from investing activities | ||||
Purchases of property, plant and equipment | ( | ( | ||
Purchases of other intangible assets | ( | ( | ||
Expenditure on product development | 14 | ( | ( | |
Loans made by the Company to subsidiary undertakings | ||||
Repayment of loan by subsidiary undertakings to the Company | ||||
Interest received | ||||
Net cash (used in)/generated from investing activities | ( | ( | ||
Cash flows from financing activities | ||||
Proceeds from issue of ordinary share capital | 28 | |||
Repayment of loan by the Company to subsidiary undertakings | ||||
Repayment of principal under leases | 24 | ( | ( | |
Lease interest paid | 24 | ( | ( | |
Interest paid | ||||
Dividends paid to Company shareholders | 12 | ( | ( | |
Net cash used in financing activities | ( | ( | ||
Net increase/(decrease) in cash and cash equivalents | ||||
Opening cash and cash equivalents | ||||
Effects of foreign exchange rates on cash and cash equivalents | ( | ( | ||
Closing cash and cash equivalents | 22 |